Mesa Laboratories Inc (MLAB)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 58.94% | 58.57% | 58.30% | 59.10% | 61.02% | 60.49% | 60.90% | 61.02% | 60.98% | 59.01% | 59.15% | 59.18% | 60.41% | 63.50% | 63.98% | 64.69% | 61.87% | 58.41% | 56.67% | 55.17% |
| Operating profit margin | 7.62% | 5.37% | 3.89% | 1.14% | -4.38% | -2.74% | -0.82% | -2.53% | 1.88% | -0.77% | -0.76% | 3.26% | 5.57% | 8.15% | 8.57% | 8.95% | 6.60% | 4.06% | 4.37% | 6.37% |
| Pretax margin | -113.50% | -116.33% | -121.05% | -127.50% | -0.28% | -0.29% | 1.86% | -0.18% | -0.07% | -1.98% | -1.63% | 1.94% | 5.21% | 3.59% | 2.14% | 1.44% | -2.57% | -2.21% | -1.27% | 2.92% |
| Net profit margin | -104.92% | -107.56% | -111.89% | -117.60% | 0.45% | -0.34% | 0.83% | 0.42% | -0.66% | -1.78% | -0.78% | 1.01% | 4.64% | 3.56% | 2.92% | 2.30% | -1.93% | -2.04% | -1.83% | 1.15% |
Based on the provided data for Mesa Laboratories Inc, the profitability ratios show fluctuations over time:
1. Gross Profit Margin:
- Mesa Laboratories' gross profit margin has generally trended upwards from around 55% in early 2020 to peaking at 64.69% in March 2021. However, it has since experienced some fluctuations but remained above 58% in recent periods, indicating the company's ability to control production costs and generate profits from its core operations.
2. Operating Profit Margin:
- The operating profit margin displays significant variability, with periods of profitability followed by losses. The margin ranged from around -4% in December 2023 to 8.95% in March 2021. It appears that Mesa Laboratories faced challenges in maintaining consistent operating profitability during the period under review.
3. Pretax Margin:
- Mesa Laboratories' pretax margin also experienced fluctuations, ranging from negative figures in some quarters to a peak of 5.21% in December 2021. The variability in pretax margin indicates the impact of factors such as operating expenses, interest payments, and non-operating activities on the company's overall profitability.
4. Net Profit Margin:
- The net profit margin mirrors the volatility in the company's financial performance, showing a mix of positive and negative margins. Mesa Laboratories struggled with negative net profit margins, with the lowest point recorded at -117.60% in March 2024. This suggests challenges in generating bottom-line profits after accounting for all expenses and taxes.
In conclusion, Mesa Laboratories Inc's profitability ratios demonstrate periods of strength in gross profit margin and fluctuations in operating, pretax, and net profit margins. The company's overall profitability seems to have been impacted by various internal and external factors during the reviewed period.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 4.14% | 2.70% | 1.98% | 0.55% | -1.26% | -0.92% | -0.28% | -0.84% | 0.63% | -0.26% | -0.22% | 0.85% | 1.26% | 1.91% | 1.94% | 2.00% | 1.38% | 0.88% | 0.92% | 1.78% |
| Return on assets (ROA) | -57.06% | -54.10% | -56.84% | -56.90% | 0.13% | -0.11% | 0.28% | 0.14% | -0.22% | -0.61% | -0.23% | 0.26% | 1.05% | 0.84% | 0.66% | 0.51% | -0.41% | -0.44% | -0.39% | 0.32% |
| Return on total capital | -167.27% | -158.84% | -174.95% | -185.67% | 1.14% | 1.00% | 2.29% | 1.11% | 1.18% | 0.04% | 0.24% | 1.93% | 3.36% | 2.72% | 2.47% | 2.74% | 0.35% | 0.50% | 0.58% | 1.84% |
| Return on equity (ROE) | -160.71% | -152.15% | -166.07% | -174.87% | 0.24% | -0.18% | 0.47% | 0.24% | -0.38% | -1.06% | -0.41% | 0.48% | 1.91% | 1.28% | 1.02% | 0.76% | -0.61% | -0.66% | -0.58% | 0.61% |
Mesa Laboratories Inc's profitability ratios exhibit fluctuations over the reported periods:
1. Operating return on assets (Operating ROA) ranged from a high of 4.14% in December 2024 to negative figures in the latter half of 2022 and 2023, indicating inconsistent operational efficiency and performance.
2. Return on assets (ROA) also showed variability, with the metric plummeting to extremely negative levels in the first half of 2024, suggesting significant challenges in generating profits from the assets employed.
3. Return on total capital displayed a similar pattern, with negative figures ranging from -185.67% in March 2024 to -158.84% in September 2024, indicating substantial difficulties in generating returns on the total capital invested.
4. Return on equity (ROE) followed a parallel trend, with the metric showing a decline and negative values over time, signifying the company's struggle in generating profits for its shareholders relative to their equity investments.
Overall, Mesa Laboratories Inc's profitability ratios demonstrate significant volatility and challenges in generating sustainable profits and returns, highlighting potential operational and financial performance issues that may require further analysis and strategic considerations.